Treatment of systemic and refractory adult-onset still's disease with Tofacitinib. efficacy of JAK/STAT Pathway inhibition

Author	dc.contributor.author	Aguilera, Sergio
Author	dc.contributor.author	Rivera, Diego
Author	dc.contributor.author	Barrera, María José
Admission date	dc.date.accessioned	2020-06-06T21:11:35Z
Available date	dc.date.available	2020-06-06T21:11:35Z
Publication date	dc.date.issued	2020
Cita de ítem	dc.identifier.citation	JCR: Journal of Clinical Rheumatology. 26(3):19, (2020)	es_ES
Identifier	dc.identifier.uri	https://repositorio.uchile.cl/handle/2250/175289
Lenguage	dc.language.iso	en	es_ES
Publisher	dc.publisher	Lippincott Williams & Wilkins	es_ES
Source	dc.source	JCR: Journal of Clinical Rheumatology	es_ES
Título	dc.title	Treatment of systemic and refractory adult-onset still's disease with Tofacitinib. efficacy of JAK/STAT Pathway inhibition	es_ES
Document type	dc.type	Artículo de revista
dcterms.accessRights	dcterms.accessRights	Acceso a solo metadatos	es_ES
Cataloguer	uchile.catalogador	ctc	es_ES
Indexation	uchile.index	Artículo de publicación ISI	es_ES